1-4 of 4
H. Sill
Close
Sort by
Journal Articles

Core-binding factor leukemia hijacks the T-cell–prone PU.1 antisense promoter

E. van der Kouwe, G. Heller, A. Czibere, J. A. Pulikkan, C. Agreiter, L. H. Castilla, R. Delwel, A. Di Ruscio, A. K. Ebralidze, M. Forte, F. Grebien, E. Heyes, L. Kazianka, J. Klinger, C. Kornauth, T. Le, K. Lind, I. A. M. Barbosa, T. Pemovska, A. Pichler, A.-S. Schmolke, C. M. Schweicker, H. Sill, W. R. Sperr, A. Spittler, S. Surapally, B. Q. Trinh, P. Valent, K. Vanura, R. S. Welner, J. Zuber, D. G. Tenen, P. B. Staber
Journal: Blood
Blood (2021) 138 (15): 1345–1358.
https://doi.org/10.1182/blood.2020008971
Published: 2021
Includes: Supplemental data
Journal Articles

Molecular investigation of secondary chronic myeloid leukemia [letter]

RC Aguiar, H Sill, A Hochhaus, JM Goldman, NC Cross
Journal: Blood
Blood (1996) 88 (7): 2808–2809.
https://doi.org/10.1182/blood.V88.7.2808.bloodjournal8872808
Published: 1996
Journal Articles

2-Chlorodeoxyadenosine as first-line treatment in bronchus-associated lymphoid tissue lymphoma [letter]

P Neumeister, W Linkesch, G Hofler, H Sill
Journal: Blood
Blood (1996) 87 (8): 3526.
https://doi.org/10.1182/blood.V87.8.3526a.bloodjournal8783526a
Published: 1996
Journal Articles

Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia

H Sill, JM Goldman, NC Cross
Journal: Blood
Blood (1995) 85 (8): 2013–2016.
https://doi.org/10.1182/blood.V85.8.2013.bloodjournal8582013
Published: 1995